Proactive Research Analyst John Savin gives the highlights from his latest research note on UK-based medical device company Creo Medical Group PLC (AIM:CREO).
Savin talks about the company’s recent performance and key products, before moving on to look at how it is positioned for the future.
He also touches on a recent placing that generated a net £32 million.
#ProactiveInvestors #CreoMedicalGroup #medicaldevices #endoscopy #cancer #surgery #healthtech #innovation #FDAapproved #microwaveenergy #bipolarenergy #roboticsurgery #USmarket #UKcompany #investing #growthpotential #researchanddevelopment #proactiveresearch #healthcare #medtech #medicalindustry #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
source